CYTOMEGALOVIRUS ANTIBODIES (CMV) PANEL- IGG & IGM

The Cytomegalovirus (CMV) Antibodies Panel – IgG & IgM is a blood test used to determine whether a person has a current, recent, or past infection with Cytomegalovirus (CMV). CMV is a common virus belonging to the herpesvirus family. While most healthy individuals experience either mild symptoms or no symptoms at all, CMV infection can cause serious health complications in pregnant women, newborn babies, organ transplant recipients, and people with weakened immune systems.

This panel measures two different antibodies produced by the body's immune system:

• CMV IgM Antibodies – Usually indicate a recent or active CMV infection.
• CMV IgG Antibodies – Indicate previous exposure to CMV and may remain detectable for life, providing evidence of past infection.

By evaluating both IgG and IgM antibodies together, healthcare providers can better understand the stage of infection and determine whether additional testing or treatment is necessary.

The CMV Antibodies Panel is frequently included in prenatal evaluations, infertility assessments, transplant workups, and investigations of unexplained fever or viral illness. It also plays an important role in diagnosing congenital CMV infection and monitoring individuals at higher risk of severe disease.

Benefits of the Test

• Detects both recent and previous CMV infections.
• Helps differentiate active infection from past exposure.
• Supports early diagnosis during pregnancy.
• Assists in evaluating newborns at risk of congenital CMV.
• Useful before organ transplantation and immunosuppressive therapy.
• Helps physicians plan appropriate treatment and monitoring.
• Simple blood test with reliable laboratory results.
• Supports timely clinical decision-making.

Why Doctors Recommend This Test

Doctors recommend the CMV IgG & IgM Panel when a patient has symptoms suggestive of CMV infection, such as prolonged fever, fatigue, swollen glands, sore throat, or unexplained illness. The test is also commonly ordered for pregnant women, couples planning pregnancy, transplant recipients, cancer patients, HIV-positive individuals, and newborns suspected of congenital CMV infection.

Measuring both antibodies helps determine whether the infection is recent, active, or from previous exposure, allowing doctors to make informed treatment and monitoring decisions.

Preparation Before the Test

No special preparation is required for this test.

Patients can eat and drink normally unless instructed otherwise by their healthcare provider. Inform your doctor about any medications, pregnancy status, recent viral infections, or immune-related medical conditions. The test requires only a routine blood sample.

Normal Reporting Time

Typically: 1–3 Working Days

Reporting time may vary depending on laboratory processing and confirmation procedures.

Who Should Take This Test?

This test is recommended for:

• Pregnant women or women planning pregnancy.
• Individuals with symptoms of viral infection.
• Organ transplant recipients.
• Patients with weakened immune systems.
• HIV-positive individuals.
• Cancer patients receiving chemotherapy.
• Newborns suspected of congenital CMV infection.
• Patients undergoing infertility evaluation.
• Individuals with prolonged fever of unknown origin.
• Anyone advised by their physician to evaluate CMV infection.